Instil Bio to close remaining UK operations, cut workforce, incur up to $5.5M in restructuring costs

Instil Bio, Inc.

Board approved restructuring plan to close Manchester, UK operations and eliminate remaining UK workforce.
Estimated aggregate restructuring costs up to $5.5M, including asset impairment ($2.2M), severance ($2.0M), and contract termination ($1.3M).
Workforce reduction expected to be substantially complete by end of 2024.
Charges are subject to assumptions; additional costs may arise not currently contemplated.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.